Aib substitution comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
Storage guidance for the finished injectable product distinguishes the unused state from the in-use state. Before first use, pens are kept refrigerated between 2 and 8 degrees Celsius, protected from light, and never frozen, since freezing can disrupt the peptide or the device. After first use, label instructions in several markets permit storage at room temperature up to about 30 degrees Celsius for a limited number of days. Solid research-grade material is normally held at or below minus 20 degrees Celsius, often with desiccant, and allowed to equilibrate before opening.
Quantification and purity assessment rely on separation methods coupled to optical or mass detection. Reversed-phase high-performance liquid chromatography resolves the intact peptide from related impurities and is the standard assay technique. Size-exclusion chromatography measures aggregates, while ion-exchange chromatography separates charge variants produced by deamidation. Mass spectrometry confirms identity and detects mass shifts of a few daltons. In biological matrices, liquid chromatography with tandem mass spectrometry is often used because immunoassays can cross-react with endogenous GLP-1 or with circulating fragments.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | free base, without counter-ion |
| Molecular weight | About 4114 Da | peptide backbone plus attached lipid chain |
| Plasma half-life | About 165 hours | supports once-weekly dosing in humans |
| Plasma protein binding | Greater than 99 percent | attributed mainly to serum albumin |
| Receptor target | GLP-1 receptor | Gs-coupled, raises intracellular cyclic AMP |
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
Reversed-phase high-performance liquid chromatography with ultraviolet detection is the dominant approach for peptide purity assessment, usually paired with mass spectrometry to confirm molecular mass and sequence. Peptide mapping by enzymatic digestion and tandem mass spectrometry locates modifications such as deamidation and oxidation. Quantitation in plasma matrices can be performed by LC-MS/MS after solid-phase extraction. Method validation follows general guidance on accuracy, precision, linearity, and limits of detection. Comparability of results between laboratories, when no shared reference standard is available, remains an open question.
Stability studies focus on deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation into higher-order species. The fatty acid side chain adds susceptibility to oxidative change and can promote self-association at high concentration. Lyophilised material is comparatively robust when kept cold and dry, while aqueous solutions require refrigeration and protection from light. Forced degradation experiments under heat, acid, base, and peroxide conditions establish the specificity of each analytical method. Which degradation route dominates under real storage conditions depends on the formulation and stays formulation-specific.
Handling guidance for research quantities calls for single-use aliquots, an inert atmosphere where practical, and avoidance of repeated freeze-thaw cycles that accelerate aggregation. Certificates of analysis typically report purity by peak area, water content, counter-ion identity, and residual solvent levels. In the scientific literature the compound is usually described by its full amino acid sequence, its registry number, or its structural class rather than by any proprietary label. Reporting standards vary between journals, and reviewers increasingly request raw chromatograms alongside tabulated purity figures. Whether current purity thresholds are adequate for every experimental context is debated.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released after nutrient intake. The molecule contains 31 amino acid residues and differs from the native sequence at several positions. A non-natural residue at position eight resists the enzyme that normally truncates the hormone, while a lysine-linked fatty diacid side chain promotes binding to serum albumin. These two modifications extend the circulating half-life from minutes to roughly one week. The peptide is produced by solid-phase synthesis followed by selective acylation, and its identity and purity are confirmed by spectrometric and chromatographic techniques.
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
== Medical uses == Andexanet alfa is used to stop life-threatening or uncontrollable bleeding in people who are taking rivaroxaban or apixaban. Studies in healthy volunteers show that the molecule binds factor Xa inhibitors and counters their anti-Xa-activity. The first published clinical trial was a prospective, open label, single group study. This study reports results on 352 people and demonstrates a reduction of anti-Xa-activity while also showing an excellent or good hemostatic efficacy in 82%. While people who were expected to die in 30 days were excluded from the study, 14% of participants died. There was no relationship between hemostatic efficacy and reduced anti-Xa-activity. The FDA demanded a randomised clinical trial which resulted in publication in 2024. The ANNEXA-I trial included 530 patients with intracerebral hemorrhage who were receiving factor Xa inhibitors. Andexanet resulted in better control of hematoma expansion than usual care, but was associated with thrombotic events, including ischemic stroke. ANNEXA-I did not have sufficient power or information to draw conclusions about the effect of andexanet on mortality, clinical deterioration, or the need for rescue therapy.
== Veterinary uses == Thiamazole is commonly used in cats to treat hyperthyroidism. Despite 20% of cats treated with thiamazole testing positive for antinuclear antibody lupus erythematosus and immune-mediated haemolytic anemia, neither condition is associated with thiamazole in cats. Hepatic toxicity also occurs in a small but notable amount of cats treated with thiamazole. In July 2024, the US Food and Drug Administration (FDA) approved Felanorm, the first generic methimazole oral solution for the treatment of hyperthyroidism in cats. Felanorm contains the same active ingredient (methimazole) as the approved brand name drug product, Felimazole Coated Tablets, which were first approved in May 2009. In addition, the FDA determined that Felanorm contains no inactive ingredients that may significantly affect the bioavailability of the active ingredient. Felanorm is sponsored by Norbrook Laboratories based in the United Kingdom.
"That way," Castro recounted on another occasion, "while the South African troops were being bled slowly dry in Cuito Cuanavale, down in the southwest...40,000 Cuban soldiers...backed by about 600 tanks, hundreds of artillery pieces, 1,000 anti-aircraft weapons, and the daring MiG-23 units that took over the skies, advanced towards the Namibian border, ready to sweep away the South African forces". As the Cuban brigades advanced, they accumulated thousands of PLAN insurgents, who departed their bases to join the offensive. The presence of so many Cuban troops effectively resuscitated PLAN's sagging fortunes, as it curtailed new South African military initiatives against the insurgents not only in Angola but South West Africa as well. Firstly, the region being occupied by the Cubans just north of the border was the same territory the SADF had monitored and patrolled for almost a decade in order to prevent PLAN infiltration into Ovamboland. Secondly, all South African units near the border had ceased routine counter-insurgency operations while they were being mobilised to resist a potential Cuban invasion. Matters were complicated further when the Cubans formed three joint battalions with PLAN fighters, each with its own artillery and armoured contingents. Due to the integration of the insurgents with Cuban personnel at the battalion level, South African patrols found it impossible to engage PLAN in Angola without risking a much larger confrontation involving aggressive and well-armed Cuban troops.
The exception is the gasoline engine powered unit, which requires a much higher level of training and topside supervision for safe use. The air-line breathing air compressor compresses clean atmospheric air and stores it in a receiver tank, using an overpressure valve to limit the pressure. The air passes through a filter and the air hose to the diver's demand valve. Small 12 volt diaphragm compressors are used for recreational hookah, with a delivery of around 1.8 bars (26 psi), which severely limits the depth to which air can be supplied. The rubber diaphragm pump usually requires no oil lubricant and delivers oil-free air. Piston compressors for hookah deliver air at higher pressures, up to about 9 bars (130 psi), and are usually driven by a small 4-stroke petrol engine. They are usually oil lubricated, using a breathing air rated mineral or synthetic oil without toxic additives. This type of compressor requires a filter to clean the air before delivery to the diver. Delivery pressure for 12 metres (39 ft) is about 20 to 35 pounds per square inch (1.4 to 2.4 bar) using a hookah regulator. Depths of 40 metres (130 ft) require up to 9 bars (130 psi). The pressure relief valve will blow off excess air delivered at low demand, to protect the system from overpressure loads, while delivering sufficient air for higher exertion. The air line hose should be rated for breathing air, with a bore of 8 to 10 millimetres (0.31 to 0.39 in). It is usually buoyant to minimise snagging on the bottom, particularly if not tended from the surface.
Sources: en.wikipedia.org
== Signs and symptoms == LNS is characterized by three major hallmarks: neurologic dysfunction, cognitive and behavioral disturbances including self-mutilation, and uric acid overproduction (hyperuricemia). Damage to the basal ganglia causes affected individuals to adopt a characteristic fencing stance due to the nature of the lesion. Some may also have macrocytic anemia due to the faulty DNA synthesis, most likely due to deficient purine synthesis that leads to a lag of cell division with respect to increases in cell mass. Virtually all patients are male; males experience delayed growth and puberty, and most develop shrunken testicles or testicular atrophy. Female carriers are at an increased risk for gouty arthritis but are usually otherwise unaffected.
The final stage of completely free movement of capital was thought to require a single currency and monetary policy, eliminating the transaction costs and fluctuations of currency exchange between member states but not between member states and third countries (TFEU article 63). Following a Report of the Delors Commission in 1988, the Treaty of Maastricht made economic and monetary union an objective, first by completing the internal market, second by creating a European System of Central Banks to coordinate common monetary policy, and third by locking exchange rates and introducing a single currency, the euro. Today, 19 member states have adopted the euro, while 9 member states have either determined to opt-out or their accession has been delayed, particularly since the European debt crisis. According to TFEU articles 119 and 127, the objective of the European Central Bank and other central banks ought to be price stability. This has been criticised for apparently being superior to the objective of full employment in the Treaty on European Union article 3.
The theca of follicule or follicular theca, develops as an outer layer of the ovarian follicle when the primary follicle becomes a secondary follicle. As the follicles continue to grow the theca becomes organized into two layers a theca interna and a theca externa. Theca cells are a group of endocrine cells in the ovary made up of stromal connective tissue surrounding the follicle. Their functions include promoting folliculogenesis and recruiting a single follicle during ovulation.
Sources: en.wikipedia.org
== See also == Antioxidant – Compound that inhibits the oxidation of other molecules Advanced glycation endproduct – Proteins or lipids chemically altered by sugar exposurePages displaying short descriptions of redirect targets
In contrast to generics, which may be chemically synthesized versions manufactured using different processes than the original biologic drug, Health Canada confirmed that Plosbrio and Poviztra differ from the existing proprietary drugs Ozempic and Wegovy only in name and packaging, and are unrelated to the generics from a regulatory perspective. The generic drug pricing formula is based on the number of generics on the market, as agreed to by suppliers and a purchasers' consortium called the Pan-Canadian Pharmaceutical Alliance. When 2 generics are available, their prices are set at 50% of the brand name price—and the May 2026 list price of brand-name Ozempic is $228 for 4 weeks' supply, plus retail markup.
==== Symmetry-breaking and chiral amplification of ribose aminooxazoline (RAO) ==== The chirality of the ribose sugar in RAO is conserved in its transformation into ribonucleotides, so obtaining RAO in its enantiopure form could lead to the formation of homochiral RNA. Experimental work shows that enantiopure RAO could be achieved via the interaction of a racemic mixture of RAO and a spin-polarized magnetic surface, such as the surface of the prebiotically abundant mineral magnetite, due to the chirality-induced spin selectivity (CISS) effect and the unique conglomerate crystallization properties of RAO (i.e. its tendency to crystallize as enantiopure crystals). In combination, these two processes can provide symmetry-breaking and amplification mechanisms for the isolation of enantiopure RAO from an initial racemic starting mixture. The CISS effect is a physical phenomena that describes the strong interaction of an electron's linear momentum and spin with a chiral molecule's electrostatic potential, allowing chiral molecules to preferentially interact with electrons of a particular spin due to lower energy spin-exchange interactions. This process explains the observation that an enantiopure layer of chiral molecules can selectively filter for electrons of a particular spin. In reverse, the CISS effect provides a symmetry breaking mechanism for RAO: spin-polarized electrons on a magnetic surface (i.e. electrons that have a net spin alignment in a particular direction) preferentially interact with one enantiomer of RAO, seeding its crystallization.
Sources: en.wikipedia.org
Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.
Albumin is the most abundant protein in plasma and carries molecules that bear fatty-acid chains. Binding shields the peptide from renal filtration and from peptidases, keeping a circulating reservoir. Slow release from this reservoir produces sustained receptor occupancy and supports infrequent dosing.
The insulinotropic effect is glucose-dependent, meaning secretion increases mainly when glucose is elevated. This property is often described as lowering the chance of hypoglycaemia when the compound is used alone. Other glucose-lowering agents used at the same time can still cause low blood glucose.
Ice formation concentrates solutes and can mechanically stress the peptide or damage the delivery device. Thawing afterwards may leave aggregates that are not visible to the eye. Refrigeration keeps the solution above its freezing point while slowing chemical degradation.